Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
PHASE3
This is a randomized multicenter study that will compare two treatment regi...
Status
Active Not Recruiting
Location
University Of Chicago Medicine Comprehensive Cancer Center
A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
PHASE3
Multiple myeloma (MM) is a plasma cell malignancy characterized by the prol...
A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)
N/A
Primary Objective:
To assess the effectiveness, in terms of overall respon...
Status
Completed
Location
University of Arkansas Medical Sciences Site Number : 8400021